公司资料
Teladoc 股价、新闻与催化剂
- 股票代码:
- TDOC
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.54 USD (-3.96%)
收盘价
最后更新: 2026年8月17日
1.36B USD
市值
股价为何变动
As of Aug 17, 2026, TDOC closed down 3.96% at $6.54. No new same-company headline was identified in the current news window.
公司概览
Global Virtual Care Platform
Teladoc Health is a global virtual care company that connects patients, providers, platforms, health plans, employers, health systems, and consumers. Its model is built around expanding access, supporting provider capacity, improving outcomes, and reducing healthcare costs through digital care delivery.
Integrated Care Segment
Integrated Care includes virtual medical services such as general medical care, expert medical services, specialty medical care, chronic condition management, mental health, enabling technologies, and enterprise telehealth solutions. This segment was more stable in the second quarter of 2026, with revenue growth and margin performance above the midpoint of company guidance.
BetterHelp Segment Transition
BetterHelp provides virtual therapy and wellness services globally. The segment is shifting from a cash-pay-heavy model toward insurance-covered services, reflecting consumer preference for insurance coverage. Demand for insurance-covered services exceeded available provider capacity in the quarter, while cash-pay pressure accelerated, leading the company to lower BetterHelp revenue expectations.
Strategic Position
Teladoc is best understood as a two-segment virtual care company. Integrated Care provides enterprise and health-plan-oriented stability, while BetterHelp offers large behavioral health exposure but is undergoing a business model transition. The company's near-term profile depends on improving BetterHelp capacity and insurance conversion while maintaining Integrated Care margins and product innovation.
未来催化剂
- Teladoc's catalysts are BetterHelp monetization, integrated-care growth, and whether chronic-care utilization can support a cleaner margin profile. The market will care about whether the company can turn a broad telehealth base into repeatable operating leverage rather than one more quarter of mixed usage.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。